OBJECTIVES The purpose of this study was to compare measures of gas exchange at rest and during exercise in patients with heart failure and preserved ejection fraction (HFpEF) with age-and sex-matched control subjects.
alveolar spaces in the lung, which potentially results in interstitial edema, impaired gas conductance, stiffer lungs, a more tachypneic pattern of breathing, and greater ventilatory drive and ventilatory inefficiency, all of which may increase the work and cost of breathing, and heighten symptoms of dyspnea during exercise (6) .
The aim of this study was to comprehensively examine the pulmonary response to exercise in HFpEF by assessing measures of gas exchange, ventilatory drive and efficiency, and the diffusion capacity of the lungs for carbon monoxide (DL CO ) and its subcomponents (pulmonary capillary blood 
METHODS
Patients with HFpEF (n ¼ 20) with EF >50% and unequivocal signs and symptoms of heart failure (Framingham criteria) were studied prospectively in as outpatients and were compensated for the study.
Exclusion criteria included significant valvular or pericardial disease, infiltrative or hypertrophic cardiomyopathy, cor pulmonale, obstructive or restrictive pulmonary disease, unstable coronary disease, atrial fibrillation, pregnancy, primary renal or hepatic disease, and inability to exercise or to suspend cardiovascular medicines. Healthy control subjects without cardiovascular disease or diabetes (n ¼ 26)
were recruited by advertisement.
Some clinical characteristics, cardiovascular function, and exercise capacity data from subjects in this study have previously been published (7); however, none of the data on pulmonary diffusion capacity, its subcomponents, or the relationships presented in this paper have been reported. All participants gave written informed consent after being provided a description of study requirements. The protocol was approved by the Mayo Clinic Institutional Review Board, and all procedures conformed to the Declaration of Helsinki. The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the paper as written.
EXERCISE TESTING PROTOCOL. Subjects were instructed to avoid strenuous physical activity for 24 hours before arrival and were studied in the upright position in an ambulatory, compensated, fasting state in a quiet, temperaturecontrolled room (21 C) . In addition, all cardiovascular medicines were withheld for 24 h before study. Ventilatory, gas exchange, heart rate, and oxygen saturation data were measured continuously during exercise. Aerobic capacity was assessed by the peak VO 2 attained during exercise. Objective exercise effort was assessed by the peak respiratory exchange ratio (VCO 2 /VO 2 ). Ventilatory efficiency was assessed by the slope of V E to VCO 2 , and ventilatory drive was assessed by the ratio of V T to T I (8) . All analyses of ventilation and gas exchange data were conducted offline in a blinded fashion. The volume of gas used to fill the rebreathe bag was determined by the V T of the subject. Consistent bag volumes were ensured by using a timed switching circuit that, given a consistent flow rate from the tank, resulted in the desired volume. For each maneuver, subjects were switched to the rebreathe bag at the end of a normal expiration (end-expiratory lung volume) and instructed to nearly empty the bag with each breath for 10 consecutive breaths. The fb during the rebreathe maneuver was controlled with a metronome at a rate of 32 breaths/min unless the intrinsic frequency was >32 breaths/min, at which time the metronome was switched off. The rebreathe bag was then emptied with a suction device and refilled immediately before the next maneuver.
All analyses of pulmonary diffusion and its subcomponents were conducted offline in a blinded fashion.
MEASUREMENT OF CARDIAC OUTPUT. Transthoracic echocardiography was used to measure stroke volume from the left ventricular (LV) outflow dimension and pulse wave Doppler as previously described (7). whereas EF, heart rate, and BP were similar in HFpEF and control subjects. None of the subjects were treated with amiodarone or had sleepdisordered breathing.
EXERCISE PERFORMANCE. Exercise time, peak workload, VO 2 at ventilatory threshold, peak VO 2 , and percent predicted peak VO 2 were all markedly impaired in patients with HFpEF compared with control subjects ( Table 2) . Borg effort and dyspnea scores in HFpEF subjects were higher at matched submaximal workload (20 W), which indicated greater perceived difficulty with low-level exercise at matched workload (Figure 1 ). At peak, Borg scores were similar between patients with HFpEF and control subjects, which was consistent with maximal subjective effort in all groups, but Borg scores relative to work performed were higher in patients with
HFpEF. There was no difference in the peak respiratory exchange ratio between the patients with HFpEF and control subjects.
VENTILATION, GAS EXCHANGE, AND LUNG DIFFUSION
AT REST AND DURING EXERCISE. There were no differences in VO 2 or measures of ventilation and breathing pattern at rest ( Table 3) . In contrast, DL CO was significantly lower in the patients with HFpEF compared with control subjects. Compared with control subjects, patients with HFpEF displayed lower D M , which reflected impaired membrane gas transfer, along with lower V C , which reflected pulmonary capillary oligemia despite evidence of higher left heart filling pressures, as noted previously (Table 3 , Figure 2 ).
During matched submaximal workload (20 W), VO 2 tended to be lower in the patients with HFpEF (p ¼ 0.06) ( Table 3 ). The DL CO was lower in the HFpEF group compared with control subjects at 20 W, which was mediated exclusively by reduced D M (Table 3) . Notably, V C increased dramatically from baseline in the HFpEF group to 20-W exercise to a level that was not different from control subjects 
DISCUSSION
This prospective study is the first to evaluate pulmonary gas diffusion both at rest and during exercise in patients with HFpEF, with separation of individual determinants of gas transfer, including D M and V C .
We demonstrate that patients with HFpEF have (Figures 2 and 3) . It may be that chronic remodeling of the alveolar-capillary membrane protects against DLCO ¼ diffusing capacity of the lungs for carbon monoxide; DM ¼ alveolarcapillary membrane conductance; fb ¼ breathing frequency; HR ¼ heart rate; Q ¼ cardiac output; SV ¼ stroke volume; VC ¼ pulmonary capillary blood volume; VT ¼ tidal volume; other abbreviations as in Table 2 . were all increased in patients with HFpEF compared with control subjects. Future study is required to clarify how hemodynamic derangements relate to observed changes in gas diffusion in HFpEF. Control subjects in the present study displayed somewhat depressed exercise capacity and mild ventilatory inefficiency. However, all were recruited a priori based upon the absence of known cardiovascular disease, and the mildly abnormal exercise findings in this group would only bias any observed group differences toward the null. Right ventricular function is known to be abnormal in HFpEF, but it was not assessed in the present study (24) .
CONCLUSIONS
The results of this study confirm our hypothesis Further study is warranted to determine how these abnormalities in lung diffusion might be targeted therapeutically to improve exercise capacity and tolerance in patients with HFpEF. 
